At Rophevac, our Research & Development is at the heart of everything we do. We are committed to pioneering innovative genomic solutions that transform healthcare and improve patient outcomes across India and globally.
Next-generation therapeutic approaches based on genomic insights
Synthetic DNA/RNA molecules for gene expression modulation in rare diseases and cancer.
Learn MoreDelivering functional mRNA for protein replacement therapy, vaccines, and regenerative medicine.
Learn MoreViral and non-viral delivery systems for inherited retinal diseases, hemophilia, and genetic disorders.
Learn MoreCRISPR/Cas systems including base editors and prime editors for ex vivo and in vivo gene correction.
Learn MoreCAR-T cell therapy, stem cell therapy, and therapeutic gene editing for cancer and regenerative medicine.
Learn MoreViruses that selectively infect and kill cancer cells while activating the immune system.
Learn MoresiRNA therapeutics for gene silencing in hereditary diseases and metabolic disorders.
Learn MoreRophevac's R&D operations are focused on advancing genetic testing technologies, developing precision medicine solutions, and creating next-generation diagnostic tools that enable early disease detection, accurate diagnosis, and personalized treatment strategies.
Scientific Publications
Patents Filed
Tests Performed Annually
Revenue in R&D